The Continental AI in antibody generation market is undergoing a notable surge, driven primarily by growing investments in biotechnology and a greater focus on personalized medicine. Experts anticipate important advancements in clinical antibody development utilizing artificial intelligence, particularly within areas like oncology and immune scienc